WEE1 and cancer: Given the limited number of drug targets addressed till today in cancer and immunology, including protein kinases, G-protein coupled receptors, and ion channels, development of new small organic molecules rightly fits the criteria for meeting the ever-increasing need for new therapeutic targets.